Literature DB >> 20670491

Treatment of a Giant Aneurysm of the Right Middle Cerebral Artery with GDCs after Extracranial to Intracranial Bypass. A Technical Case Report.

E Castro1, F Fortea, F Villoria, L Muñoz, C Benito, F Morales.   

Abstract

SUMMARY: A case of a giant aneurysm of the right middle cerebral artery treated with Guglielmi detachable coils is reported. Extracranial to intracranial bypass had previously been performed and surgical trapping had been attempted. During the endovascular procedure, balloon test occlusion of the middle cerebral artery was performed in order to demonstrate clinical and angiographic tolerance to parent vessel occlusion. A previous occlusion test in the right common carotid artery did not show sufficient flow through the bypass to perform safe parent vessel occlusion. Diagnostic imaging, the endovascular procedure, and haemodynamic aspects in cases in which parent vessel occlusion is required after extracranial-intracranial bypass are described and the literature is reviewed.

Entities:  

Year:  2001        PMID: 20670491      PMCID: PMC4268665          DOI: 10.1177/159101999900500109

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  11 in total

Review 1.  Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1965 to 1992.

Authors:  C G Drake; S J Peerless
Journal:  J Neurosurg       Date:  1997-08       Impact factor: 5.115

2.  Rupture of a giant basilar aneurysm after saphenous vein interposition graft to the posterior cerebral artery. Case report.

Authors:  R C Heros; A M Ameri
Journal:  J Neurosurg       Date:  1984-08       Impact factor: 5.115

3.  Revascularization and aneurysm surgery: current techniques, indications, and outcome.

Authors:  M T Lawton; M G Hamilton; J J Morcos; R F Spetzler
Journal:  Neurosurgery       Date:  1996-01       Impact factor: 4.654

4.  Treatment of inoperable carotid aneurysms with endovascular carotid occlusion after extracranial-intracranial bypass surgery.

Authors:  L Hacein-Bey; E S Connolly; H Duong; M C Vang; R M Lazar; R S Marshall; W L Young; R A Solomon; J Pile-Spellman
Journal:  Neurosurgery       Date:  1997-12       Impact factor: 4.654

5.  Use of detachable balloons for proximal artery occlusion in the treatment of unclippable cerebral aneurysms.

Authors:  A J Fox; F Viñuela; D M Pelz; S J Peerless; G G Ferguson; C G Drake; G Debrun
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

6.  Aneurysm rupture after parent vessel sacrifice: treatment with Guglielmi detachable coil embolization via retrograde catheterization: case report.

Authors:  J H Gurian; F Viñuela; Y P Gobin; V E Waston; G R Duckwiler; G Gulielmi
Journal:  Neurosurgery       Date:  1995-12       Impact factor: 4.654

7.  Hunterian proximal arterial occlusion for giant aneurysms of the carotid circulation.

Authors:  C G Drake; S J Peerless; G G Ferguson
Journal:  J Neurosurg       Date:  1994-11       Impact factor: 5.115

8.  Treatment of large and giant fusiform intracranial aneurysms with Guglielmi detachable coils.

Authors:  Y P Gobin; F Viñuela; J H Gurian; G Guglielmi; G R Duckwiler; T F Massoud; N A Martin
Journal:  J Neurosurg       Date:  1996-01       Impact factor: 5.115

9.  Endovascular occlusion of vertebral arteries in the treatment of unclippable vertebrobasilar aneurysms.

Authors:  A Aymard; Y P Gobin; J E Hodes; S Bien; D Rüfenacht; D Reizine; B George; J J Merland
Journal:  J Neurosurg       Date:  1991-03       Impact factor: 5.115

10.  Rupture of a giant carotid aneurysm after extracranial-to-intracranial bypass surgery.

Authors:  J A Anson; J L Stone; R M Crowell
Journal:  Neurosurgery       Date:  1991-01       Impact factor: 4.654

View more
  1 in total

1.  Combined neuroform intracranial stent and bioactive matrix detachable coil for embolization of a broad-necked persistent primitive trigeminal artery aneurysm. A case report.

Authors:  Q P Zhao; T L Li; C Z Duan; G Z Chen
Journal:  Interv Neuroradiol       Date:  2005-06-17       Impact factor: 1.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.